Op-Eds Trump keeps winning the drug trade war. So why isn’t he talking about it? Stacy Washington · October 2, 2026 9:00 am
Op-Eds AARP’s $200 billion mirage: How price controls kill tomorrow’s medicine Saul Anuzis · September 28, 2026 8:00 am
Op-Eds Price caps sound great — until you have cancer and a two-year waitlist Nicole Sheahan · September 15, 2026 11:00 am
Op-Eds Mamdani’s rent freeze leaves half of New Yorkers out in the cold Sam Raus · July 2, 2026 7:00 am
Columnists Higher taxes and reckless spending: Welcome to Mamdani’s NYC Zachary Faria · February 20, 2026 5:27 am
Business Price controls won’t work better on credit cards than groceries Tiana Lowe Doescher · January 16, 2026 5:05 am
Faith, Freedom, and Self-Reliance No excuse for price floors in rare earths dispute Ryan Young, Paige Lambermont · October 25, 2025 7:00 am
Faith, Freedom, and Self-Reliance There are more ways to lower drug prices than by executive order Nicholas Armstrong · August 27, 2025 6:00 am
Fairness and Justice What Zohran Mamdani can learn about housing from Javier Milei Jon Miltimore · July 16, 2025 6:00 am
Faith, Freedom, and Self-Reliance How Medicaid and Medicare drug price controls threaten seniors Mark Gibbons · May 29, 2025 6:00 am
Op-Eds
